Krebs Shelly J, McBurney Sean P, Kovarik Dina N, Waddell Chelsea D, Jaworski J Pablo, Sutton William F, Gomes Michelle M, Trovato Maria, Waagmeester Garret, Barnett Susan J, DeBerardinis Piergiuseppe, Haigwood Nancy L
Division of Pathobiology and Immunology, Oregon National Primate Research Center, Oregon Health and Sciences University, Beaverton, OR, United States of America.
Viral Vaccines Program, Seattle Biomedical Research Institute, Seattle, WA, United States of America.
PLoS One. 2014 Dec 16;9(12):e113463. doi: 10.1371/journal.pone.0113463. eCollection 2014.
Developing a vaccine that overcomes the diversity of HIV-1 is likely to require a strategy that directs antibody (Ab) responses toward conserved regions of the viral Envelope (Env). However, the generation of neutralizing Abs (NAbs) targeting these regions through vaccination has proven to be difficult. One conserved region of particular interest is the membrane proximal external region (MPER) of Env located within the gp41 ectodomain. In order to direct the immune response to this region, the MPER and gp41 ectodomain were expressed separately as N-terminal fusions to the E2 protein of Geobacillus stearothermophilus. The E2 protein acts as a scaffold by self-assembling into 60-mer particles, displaying up to 60 copies of the fused target on the surface. Rabbits were immunized with E2 particles displaying MPER and/or the gp41 ectodomain in conjunction with DNA encoding full-length gp160. Only vaccines including E2 particles displaying MPER elicited MPER-specific Ab responses. NAbs were elicited after two immunizations that largely targeted the V3 loop. To overcome V3 immunodominance in the DNA component, E2 particles displaying MPER were used in conjunction with gp160 DNA lacking hypervariable regions V2, V3, or combined V1V2V3. All rabbits had HIV binding Ab responses and NAbs following the second vaccination. Using HIV-2/HIV-1 MPER chimeric viruses as targets, NAbs were detected in 12/16 rabbits after three immunizations. Low levels of NAbs specific for Tier 1 and 2 viruses were observed in all groups. This study provides evidence that co-immunizing E2 particles displaying MPER and gp160 DNA can focus Ab responses toward conserved regions of Env.
开发一种能克服HIV-1多样性的疫苗可能需要一种将抗体(Ab)反应导向病毒包膜(Env)保守区域的策略。然而,通过疫苗接种产生靶向这些区域的中和抗体(NAbs)已被证明是困难的。一个特别令人感兴趣的保守区域是位于gp41胞外域内的Env膜近端外部区域(MPER)。为了将免疫反应导向该区域,MPER和gp41胞外域分别作为嗜热栖热放线菌E2蛋白的N端融合蛋白表达。E2蛋白通过自组装成60聚体颗粒作为支架,在表面展示多达60个融合靶标的拷贝。用展示MPER和/或gp41胞外域的E2颗粒与编码全长gp160的DNA联合免疫兔子。只有包含展示MPER的E2颗粒的疫苗引发了MPER特异性Ab反应。两次免疫后引发了主要靶向V3环的NAbs。为了克服DNA成分中的V3免疫优势,将展示MPER的E2颗粒与缺乏高变区V2、V3或组合V1V2V3的gp160 DNA联合使用。第二次接种后,所有兔子都产生了HIV结合Ab反应和NAbs。以HIV-2/HIV-1 MPER嵌合病毒为靶标,三次免疫后在12/16只兔子中检测到NAbs。所有组中均观察到针对1级和2级病毒的低水平NAbs。这项研究提供了证据,表明共同免疫展示MPER的E2颗粒和gp160 DNA可以将Ab反应聚焦于Env的保守区域。